Dynamic ERK signaling regulation in intestinal tumorigenesis

Dynamic ERK signaling regulation in intestinal tumorigenesis

Extracellular signal-regulated kinase (ERK) plays a critical role in tissue homeostasis and tumorigenesis. By utilizing live imaging approaches, we recently uncovered ERK activity dynamics in the intestinal epithelium. Notably, we showed that ERK activity dynamics are defined by composite regulation...

Full description

Bibliographic Details
Main Authors:	Yu Muta, Michiyuki Matsuda, Masamichi Imajo
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-09-01
Series:	Molecular & Cellular Oncology
Subjects:	erk map kinase egfr erbb2 the intestinal epithelium tumorigenesis in vivo imaging
Online Access:	http://dx.doi.org/10.1080/23723556.2018.1506684

Similar Items

Divergent Dynamics and Functions of ERK MAP Kinase Signaling in Development, Homeostasis and Cancer: Lessons from Fluorescent Bioimaging
by: Yu Muta, et al.
Published: (2019-04-01)

Intestinal Gasdermins for regulation of inflammation and tumorigenesis
by: Wenbin Gong, et al.
Published: (2022-11-01)

ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells
by: Akira Hirota, et al.
Published: (2022-11-01)

ERK Dephosphorylation through MKP1 Deacetylation by SIRT1 Attenuates RAS-Driven Tumorigenesis
by: Ok-Seon Kwon, et al.
Published: (2020-04-01)

Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases
by: Andrew J. Shih, et al.
Published: (2011-03-01)

Intercellular propagation of extracellular signal-regulated kinase activation revealed by in vivo imaging of mouse skin
by: Toru Hiratsuka, et al.
Published: (2015-02-01)

ERK signals: scaffolding scaffolds?
by: Piero eCrespo, et al.
Published: (2016-05-01)

Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis
by: Audrey Sirvent, et al.
Published: (2020-07-01)

Dabrafenib Promotes Schwann Cell Differentiation by Inhibition of the MEK-ERK Pathway
by: Kyuhee Park, et al.
Published: (2021-04-01)

ANGPTL4 regulates ovarian cancer progression by activating the ERK1/2 pathway
by: Jiaqi Xu, et al.
Published: (2024-02-01)

Constitutive Immune Activity Promotes Tumorigenesis in Drosophila Intestinal Progenitor Cells
by: Kristina Petkau, et al.
Published: (2017-08-01)

Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice
by: Kathrin Hedegger, et al.
Published: (2020-08-01)

A Critical Review on In Vitro and Ex Vivo Models of the Intestinal Epithelium of Humans and Monogastric Animals
by: Célia Maria Costa, et al.
Published: (2024-03-01)

Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling
by: Lanming Cheng, et al.
Published: (2020-06-01)

ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled?
by: Simon J. Cook, et al.
Published: (2022-07-01)

ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma
by: Fatih M. Uckun, et al.
Published: (2022-10-01)

JNK, p38, ERK, and SGK1 Inhibitors in Cancer
by: Jonas Cicenas, et al.
Published: (2017-12-01)

Myeloid p38α signaling promotes intestinal IGF‐1 production and inflammation‐associated tumorigenesis
by: Catrin Youssif, et al.
Published: (2018-07-01)

ECSIT Is a Critical Factor for Controlling Intestinal Homeostasis and Tumorigenesis through Regulating the Translation of YAP Protein
by: Yuying Jiang, et al.
Published: (2023-09-01)

Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models
by: Gupta Parul, et al.
Published: (2012-07-01)

Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody
by: Yu-Wei Lin, et al.
Published: (2022-12-01)

Phosphorylation of Extracellular Signal-Regulated Kinase after Transient Cerebral Ischemia in Hyperglycemic Rats
by: Ping-An Li, et al.
Published: (2001-02-01)

DCLK1 autoinhibition and activation in tumorigenesis
by: Linna Cheng, et al.
Published: (2022-01-01)

On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer
by: Fadia Boudghene-Stambouli, et al.
Published: (2022-12-01)

ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation
by: Xin Liu, et al.
Published: (2019-06-01)

Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies
by: Ying Wei, et al.
Published: (2023-03-01)

Extracellular Signal-Regulated Kinase (ERK) Inhibitors in Oncology Clinical Trials
by: Haelee M Chin, et al.
Published: (2019-02-01)

The secret life of kinases: functions beyond catalysis
by: Romano David, et al.
Published: (2011-10-01)

Does EGFR Signaling Mediate Orexin System Activity in Sleep Initiation?
by: Marina Kniazkina, et al.
Published: (2023-05-01)

Salinomycin causes dedifferentiation via the extracellular signal-regulated kinase (ERK) pathway in rabbit articular chondrocytes
by: Seon-Mi Yu, et al.
Published: (2015-02-01)

The under-appreciated promiscuity of the epidermal growth factor receptor family.
by: Sean P Kennedy, et al.
Published: (2016-08-01)

Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
by: Zhang Xiangchao, et al.
Published: (2023-06-01)

Composite regulation of ERK activity dynamics underlying tumour-specific traits in the intestine
by: Yu Muta, et al.
Published: (2018-06-01)

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma
by: Xuejiao Liu, et al.
Published: (2019-05-01)

Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs
by: Louise Pinet, et al.
Published: (2021-11-01)

Somatic ERK activation during transit amplification is essential for maintaining the synchrony of germline divisions in Drosophila testis
by: Samir Gupta, et al.
Published: (2018-07-01)

Resveratrol Down-Regulates Myosin Light Chain Kinase, Induces Apoptosis and Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in Rats
by: Shi-Tang Ma, et al.
Published: (2013-01-01)

Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling
by: Yu D, et al.
Published: (2021-02-01)

Dietary Advanced Glycation End products interacting with the intestinal epithelium: What do we really know?
by: Fleur A.C. Jansen, et al.
Published: (2023-07-01)

Cellular Composition and Differentiation Signaling in Chicken Small Intestinal Epithelium
by: Haihan Zhang, et al.
Published: (2019-10-01)